Interview of Hervé Affagard, CEO and co-founder of MaaT Pharma, for Lyon Décideurs – Bourses & Valeurs during the Lyon Pôle Bourse Forum in September 2022. (French only)
Media
October 12, 2022: Interview of Hervé Affagard in Lyon Décideurs – Bourses & Valeurs
Date : 12/10/2022
We are a clinical-stage microbiome therapeutics company aiming to improve survival in cancer.
© 2025 MaaT Pharma. MaaT Pharma’s mission is to restore microbiome function to treat life-threatening diseases
